Cynthia Sirard serves as Executive at LEAP THERAPEUTICS, INC., where they oversee executive responsibilities. Since joining the company, Cynthia Sirard has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 26, 2024 involved exercising options for 5,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jan 26, 2024 | LPTX | $0 | Option Exercise | 5,000 | $N/A | Discretionary |
Cynthia Sirard currently holds 5,000 shares of LEAP THERAPEUTICS, INC. (LPTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Cynthia Sirard has been a net neutral trader of LPTX stock. They have purchased $0 and sold $0 worth of shares.
Cynthia Sirard's most recent insider trade was on Jan 26, 2024, when they sold 5,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted